Circulating microRNA expression profiles in ovarian cancer

Journal of Obstetrics and Gynaecology

Volumn 34, Issue 7, 2014, Pages 620-624

  Ayaz, L ^a   Cayan F ^b   Balci, S ^b   Gorur A ^b   Akbayir, S ^b   Yaroʇlu, H Yildirim ^c   Unal, N Doʇruer ^b   Tamer, L ^b  

^a TRAKYA UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

^c TOROS UNIVERSITY   (Turkey)

Author keywords

MicroRNA; MiRNA; Ovarian cancer; Plasma miRNA; RT PCR

Indexed keywords

MICRORNA; MICRORNA 106B-5P; MICRORNA 125B-5P; MICRORNA 126-3P; MICRORNA 135-5P; MICRORNA 146A-5P; MICRORNA 150-5P; MICRORNA 191-5P; MICRORNA 193B-3P; MICRORNA 19A-3P; MICRORNA 19B; MICRORNA 20A-5P; MICRORNA 218-5P; MICRORNA 223-3P; MICRORNA 24-3P; MICRORNA 25-3P; MICRORNA 27A-3P; MICRORNA 27B-3P; MICRORNA 29A-3P; MICRORNA 29C-3P; MICRORNA 30B-5P; MICRORNA 30C-5P; MICRORNA 320A; MICRORNA 324-3P; MICRORNA 328; MICRORNA 34C-5P; MICRORNA 451; MICRORNA 574-3P; MICRORNA 576-3P; MICRORNA 92A-3P; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; MICROFLUIDIC ANALYSIS; MULTIPLEX POLYMERASE CHAIN REACTION; OVARY CANCER; PRIORITY JOURNAL; UPREGULATION; AGED; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; OVARY TUMOR;

ADULT; AGED; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; MIDDLE AGED; OVARIAN NEOPLASMS;

EID: 84925234812     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2014.919998     Document Type: Article

References (30)

1. Ahmed FY, Wiltshaw E, Ahern RP, Nicol B, Shepherd J, Blake P et al. 1996. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. Journal of Clinical Oncology 14:2968-2975.
2. Bast Jr RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H et al. 1983. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. New England Journal of Medicine 309:883-887.
3. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O. 2005. Identification of hundreds of conserved and nonconserved human microRNAs. Nature Genetics 37:766-770.
4. Cai H, Yuan Y, Hao YF, Guo TK, Wei X, Zhang YM. 2013. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Medical Oncology 30:452.
5. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih IeM, Zhang Y et al. 2008. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 3:e2436.
6. Duffy MJ, Bonfrer JM, Kulpa J, Rustin GJ, Soletormos G, Torre GC et al. 2005. CA125 in ovarian cancer: European group on tumor markers guidelines for clinical use. International Journal of Gynecological Cancer 15:679-691.
7. Esquela-Kerscher A, Slack FJ. 2006. Oncomirs - microRNAs with a role in cancer. Nature Reviews Cancer 6:259-269.
8. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E et al. 2007. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proceedings of the National Academy of Sciences USA 104:15805-15810.
9. Filipowicz W, Bhattacharyya SN, Sonenberg N. 2008. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nature Reviews. Genetics 9:102-114.
10. Garcia, M, Jemal A, Ward EM, Center MM, Hao Y, Siegel RL et al. 2007. Global cancer facts, figures 2007. Atlanta: American Cancer Society.
11. Häusler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S et al. 2010. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. British Journal of Cancer 103:693-700.
12. Hu X, Macdonald DM, Huettner PC, Feng Z, El Naqa IM, Schwarz JK. 2009. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecologic Oncology 114:457-464.
13. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P et al. 2007. MicroRNA signatures in human ovarian cancer. Cancer Research 67:8699-8707.
14. Jacobs I, Davies AP, Bridges J, Stabile I, Fay T, Lower A et al. 1993. Prevalence screening for ovarian cancer in post-menopausal women by CA-125 measurement and ultrasonography. British Medical Journal 306:1030-1034.
15. Jacobs IJ, Menon U. 2004. Progress and challenges in screening for early detection of ovarian cancer. Molecular and Cellular Proteomics 3:355-366.
16. Kosaka N, Iguchi H, Ochiya T. 2010. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Science 101:2087-2092.
17. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M et al. 2008. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Molecular Cancer 7:35.
18. Marchini S, Cavalieri D, Fruscio R, Calura E, Garavaglia D, Nerini IF et al. 2011. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. Lancet Oncology 12:273-285.
19. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F et al. 2009. A novel and universal method for miRNA RT-qPCR data normalisation. Genome Biology 10:R64.
20. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH et al. 2008. MicroRNA expression profiles in serous ovarian carcinoma. Clinical Cancer Research 14:2690-2695.
21. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29:2002-2007.
22. Piver MS, Malfetano J, Baker TR, Hempling RE. 1992. Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy. Gynecologic Oncology 46:357-360.
23. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. 2009. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecologic Oncology 112:55-59.
24. Shih KK, Qin LX, Tanner EJ, Zhou Q, Bisogna M, Dao F et al. 2011. A microRNA survival signature (MiSS) for advanced ovarian cancer. Gynecologic Oncology 121:444-450.
25. Tavazoie SF1, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD et al. 2008. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147-152.
26. Taylor DD, Gercel-Taylor C. 2008. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecologic Oncology 110:13-21.
27. Wright JD, Shah M, Mathew L, Burke WM, Culhane J, Goldman N et al. 2009. Fertility preservation in young women with epithelial ovarian cancer. Cancer 115:4118-4112.
28. Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O'Briant K, Godwin AK et al. 2009. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS ONE 4:e5311.
29. Yang HF, Zheng WH, Zhao WT, Guan CY, An J. 2013. Roles of miR-590-miR-55p and miR-590-miR-53p in the development of hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Bao (Journal of Southern Medical University) 33:804-811.
30. Zhang L1, Volinia S, Bonome T, Calin GA, Greshock J, Yang N et al. 2008. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proceedings of the National Academy of Sciences USA 105:7004-7009.